Business Standard

J&J to pay Rs 25 lakh each to 67 victims of faulty ASR hip implants

J&J says it will pay other patients only if they fulfil criteria set by company

Johnson & Johnson's, J&J
Premium

Aashish Aryan New Delhi
Pharmaceutical major Johnson & Johnson (J&J) on Thursday told the Delhi High Court (HC) it was ready to pay Rs 25 lakh each to the 67 victims of its articular surface replacement (ASR) hip implants. These are the patients who have undergone revision surgeries and have been identified by the company from a list of 289 patients identified by the Central Drugs Standard Control Organization (CDSCO).

Of the 289 faulty hip implant victims identified, 93 patients had undergone revision surgeries, the central government told the HC. The company, however, said it could reach only 67 patients and would pay Rs 25

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 30 2019 | 7:44 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com